- Filed
- Mar 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Feb 28, 2026 | 6.45M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2026 | 6.43M sh |
| Shares Diluted | Q1 2026 · Jan 31, 2025 | 6.46M sh |
| Capex | Q1 2026 · Jan 31, 2026 | $71K |
| Capex | Q1 2026 · Jan 31, 2025 | $93K |
| Operating Cash Flow | Q1 2026 · Jan 31, 2026 | −$616K |
| Operating Cash Flow | Q1 2026 · Jan 31, 2025 | $10.34M |
| Cash And Equivalents | Q1 2026 · Jan 31, 2026 | $48.01M |
| Cash And Equivalents | Q1 2026 · Oct 31, 2025 | $48.71M |
| Stockholders Equity | Q1 2026 · Jan 31, 2026 | $195.03M |
| Stockholders Equity | Q1 2026 · Oct 31, 2025 | $198.79M |
| Stockholders Equity | Q1 2026 · Jan 31, 2025 | $198.14M |
| Stockholders Equity | Q1 2026 · Oct 31, 2024 | $207.17M |
| Current Liabilities | Q1 2026 · Jan 31, 2026 | $53.22M |
| Current Liabilities | Q1 2026 · Oct 31, 2025 | $52.02M |
| Current Assets | Q1 2026 · Jan 31, 2026 | $222.72M |
| Current Assets | Q1 2026 · Oct 31, 2025 | $225.08M |
| Total Assets | Q1 2026 · Jan 31, 2026 | $261.54M |
| Total Assets | Q1 2026 · Oct 31, 2025 | $264.3M |
| Eps Diluted | Q1 2026 · Jan 31, 2026 | −$0.54 |
| Eps Diluted | Q1 2026 · Jan 31, 2025 | −$0.67 |
| Eps Basic | Q1 2026 · Jan 31, 2026 | −$0.54 |
| Eps Basic | Q1 2026 · Jan 31, 2025 | −$0.67 |
| Sga Expense | Q1 2026 · Jan 31, 2026 | $11.11M |
| Sga Expense | Q1 2026 · Jan 31, 2025 | $10.38M |
| Net Income | Q1 2026 · Jan 31, 2026 | −$3.47M |
| Net Income | Q1 2026 · Jan 31, 2025 | −$4.32M |
| Operating Income | Q1 2026 · Jan 31, 2026 | −$3.17M |
| Operating Income | Q1 2026 · Jan 31, 2025 | −$2.09M |
| Gross Profit | Q1 2026 · Jan 31, 2026 | $7.94M |
| Gross Profit | Q1 2026 · Jan 31, 2025 | $8.29M |
| Cost Of Revenue | Q1 2026 · Jan 31, 2026 | $34.93M |
| Cost Of Revenue | Q1 2026 · Jan 31, 2025 | $38.12M |
| Revenue | Q1 2026 · Jan 31, 2026 | $42.87M |
| Revenue | Q1 2026 · Jan 31, 2025 | $46.41M |